Our Cool Team

Gordie E. Nye has served as President and Chief Executive Officer and Director since September 2009. From August 2003 to July 2009, Mr. Nye served as general partner of Prism VentureWorks, a venture capital firm, where he was a member of the life sciences investment team. As a Managing Director of Group Outcome LLC (an angel investment club formed in 1998), Mr. Nye was both an angel investor in and the interim Chief Executive Officer for REVA Medical, Inc., an ASX-listed medical device company. Mr. Nye remains a Director of REVA. Prior to that time, he served as President and Chief Executive Officer of two former Johnson & Johnson divisions (“A” Company Orthodontics, Inc. and Critikon Company, LLC) after they were acquired in management buyouts. He has also held a variety of marketing, sales, and general management roles for L.A. Gear, Inc., Olin Ski Company, Inc., Reebok, Ltd., and The Gillette Company. Mr. Nye also served on the board of directors of Insulet, Inc., a medical device company, from 2004 to 2008. Mr. Nye received his M.B.A from the Amos Tuck School of Business at Dartmouth College, where he also received his undergraduate degree. He currently sits on the board of Systagenix Wound Management, Ltd., and REVA Medical, Inc.

Joshua T. Brumm has served as Vice President of Corporate Development and Investor Relations since October 2011. Previously, Mr. Brumm has served as Vice President of Corporate Development from July 2011 to October 2011, as Senior Managing Director, International Sales and Corporate Development from January 2011 to July 2011, as Director, International Sales and Corporate Development from June 2010 to January 2011, and Director, Corporate Development and Strategy from December 2009 to June 2010. Prior to joining ZELTIQ, Mr. Brumm served as Director of Finance at Proteolix, Inc. from March 2009 to December 2009, at which time it was acquired by Onyx Pharmaceuticals, and as a Healthcare Investment Banking Associate with Citigroup Global Markets, Inc. from June 2007 to March 2009. Prior to June 2007, he served as Chief Executive Officer and Founder of Nu-Ag Distribution, LLC from December 2002 to the company’s sale in June 2007 and as a Healthcare Investment Banking Analyst at Morgan Stanley from May 2001 to August 2002. Mr. Brumm graduated summa cum laude and holds a B.B.A. from the University of Notre Dame.

Dennis J. Jarvis has served as Chief Marketing Officer since January 2011. Prior to joining ZELTIQ, Mr. Jarvis served as Vice President of Marketing at Ophthonix, Inc., a venture-backed vision correction company, from August 2003 to December 2010 and as Group Director of Marketing with VISTAKON, Johnson & Johnson Vision Care from June 1998 to December 2001. Prior to crossing over into the medical technology field, he held senior management positions focusing on marketing, sales, and market research with prominent consumer companies including The Gillette Company, where he was responsible for launching 15 new products, as well as Reebok, Ltd. and Spencer Gifts, a division of NBC-Universal. Mr. Jarvis began his career with Marsteller Inc., the advertising arm of leading global public relations and communications firm Burson-Marsteller. Mr. Jarvis earned his Ph.D. and Masters of Arts in Communications from Southern Illinois University and his B.S. from The College at Brockport, State University of New York. He also taught Marketing Management in the M.B.A program at Simmons College in Boston.

Kristine N. Tatsutani Ph.D. has served as Chief Technology Officer and Vice President of Enhanced Clinical Outcomes since May 2011. Dr. Tatsutani has 17 years of experience in the field of medical research and medical devices specifically focused in cryogenic applications in oncology, interventional cardiology, electrophysiology, and aesthetic medicine. Prior to joining ZELTIQ, Dr. Tatsutani served as Vice President, Clinical and Scientific Development at MyoScience, Inc., a company developing a cryogenic technology for another aesthetic application, from June 2008 to May 2011. Before that, she held scientific and clinical leadership positions at Boston Scientific from March 2005 to May 2008, and at CryoVascular Systems, Inc. from September 1998 to March 2005. Dr. Tatsutani earned her Ph.D. in Mechanical Engineering, specializing in cryobiology, as well as her Master of Science and Bachelor of Science in Mechanical Engineering at the University of California, Berkeley. She has multiple patents and scientific publications in the field of cryobiology and cryogenic medicine.

Richard W. Poinsett has served as Senior Vice President of Operations since July 2011. Prior to that time, he served as Vice President of Reliability, Integrity and Supply Chain from June 2010 to July 2011, leading our manufacturing, quality assurance, and regulatory initiatives. He also manages the execution of global expansion plans to accelerate our growth in the aesthetic device market. Prior to joining ZELTIQ, Mr. Poinsett served as Vice President of Regulatory Affairs, Quality Assurance and Engineering at Greer Laboratories, Inc. from November 2004 to June 2010; Vice President, Development, Regulatory Affairs and Quality Assurance for In Sound Medical, Inc. from October 2003 to June 2004; and General Manager of REVA Medical, Inc. from September 2000 to December 2003. Prior to REVA Medical, Inc., he held several senior operations management positions at medical device companies. Mr. Poinsett brings over 20 years of senior management experience in operations, R&D, quality assurance, and regulatory affairs to ZELTIQ, primarily in the medical device sector. Mr. Poinsett holds an M.B.A. from Pepperdine University and a B.S. in electrical engineering from Purdue University.

Stephen W. Atkinson has served as Senior Vice President of International since July 2011. Prior to joining ZELTIQ, Mr. Atkinson served from July 2008 to June 2011 as Chief Executive Officer at SYSTAGENIX, a private equity backed wound care company that he carved out from Johnson & Johnson, with direct sales to 15 countries and indirect sales to over 30 more. From 2002 to 2008, Mr. Atkinson served as Area Vice President at CR BARD Inc., a diversified medical device company, where he was responsible for the business in several European countries. Before that, Mr. Atkinson served as Vice President and Managing Director of Europe, Middle East & Africa for Critikon LLC, a private equity backed company that was divested to GE Medical, where he continued to serve as a European Vice President for their Sub-Acute Care, Supplies, and Accessories business. Mr. Atkinson started his career in medical devices with ten years of service at Johnson and Johnson in various sales, marketing, and general management roles. Mr. Atkinson was awarded a B.A. with Honors from the Carnegie School of Leeds Metropolitan University in the United Kingdom, and in 2005 completed the Advanced Executive Program at the Kellogg Business School at Northwestern University in Chicago.

David H. Heagy has served as Vice President of North American Sales since April 2010 and had previously served as Director of Sales since March 2008. Before joining ZELTIQ, he served as Western Regional Sales Director at Sciton, Inc., a manufacturer of aesthetic lasers, from March 2005 to March 2008. He also has been employed at Thermage, Oratec Interventions, Sulzer Spinetech, Boston Scientific, and U.S. Surgical in various sales and sales management positions. Mr. Heagy has 19 years of experience in medical devices introducing new technologies in aesthetics, orthopedics, interventional cardiology, and laparoscopic surgery. Mr. Heagy earned his B.A. in Marketing from the University of Florida.

Tim Holt has served as Vice President of Sales Operations since January 2011 and previously served as Director, Worldwide Customer Service from April 2008 to January 2011. Prior to joining ZELTIQ, Mr. Holt served as Director of Customer Service at Reliant Technologies from August 2003 to March 2008 and Director of Operations at GCI, Inc. from August 2001 to August 2003. With 11 years of experience building cutting-edge customer-facing service teams in customer care, sales support, and technical service, Mr. Holt is now responsible for establishing high levels of quality, accuracy, and process consistency for the sales organization. Mr. Holt holds a B.B.A. in Marketing from Ohio University and an M.B.A. in Management from Campbell University.

Carl Lamm has served as Vice President of Manufacturing and Supply Chain since July 2011 and previously served as Senior Director of Supply Chain from April 2008 to July 2011. Prior to joining ZELTIQ, Mr. Lamm served as Manufacturing Manager at Thoratech Corporation from February 2007 to March 2008, as Operations Manager at Varian Inc. from December 1997 to February 2007 and Director of Logistics and Materials at Orthopedic Technology from January 1994 to December 1997. With over 20 years of operations experience in Class II and III Medical Device and high technology companies managing supply chain and manufacturing functions, Mr. Lamm is now responsible for establishing a flexible, scalable, cost effective and quality driven manufacturing and supply chain organization. Mr. Lamm holds a BA in Economics from the University of Washington and an M.B.A from Saint Mary’s College.

Richard Markle has served as Vice President of Finance since July 2011 and previously served as Corporate Controller since October 2007. Prior to joining ZELTIQ, Mr. Markle served as Group Controller at JM Huber from August 2006 to June 2007, Corporate Controller at ArthroCare from October 2002 to June 2005 and Vice President of Finance & Administration at Kinetics Systems from September 2000 to June 2002. With over 20 years of experience building accounting and finance teams in both private and public companies, developing integrated financial tools and control systems to insure accurate financial reporting, Mr. Markle is responsible for establishing the SOX compliant financial systems, policies and procedures necessary to support the management team and inform our investors on the financial health of the business. Mr. Markle holds a B.S, in Operations Management from California State College at Long Beach and an M.B.A. in Finance from Santa Clara University.

James McCutcheon has served as Vice President of International Finance since September 2011. Prior to joining ZELTIQ, Mr. McCutcheon was Chief Financial Officer at venture-backed Masters Pharmaceuticals, a global pharmaceutical distributor. He was Finance and IT director at IDIS Group, a private-equity backed pharmaceutical service provider from 2007 to 2010. Prior to this Mr. McCutcheon was Deputy Group Finance Director at Watermark Group plc, an airline services provider from 2003 to 2007. From 1998 to 2002, Mr. McCutcheon was Finance Director of EMEA for Critikon LLC, a private-equity backed company that was divested to GE Medical in 2001 where he continued to serve as Finance Director, EMEA. He spent the first ten years of his career at Glaxo SmithKline, firstly as Middle East Finance Manager before relocating in 1993 to Warsaw, Poland to become Finance Director for Poland, Hungary and the Czech Republic through to 1998. Mr. McCutcheon was awarded a B.A. with Honors in Business and Finance from South Bank University in London, the United Kingdom before obtaining his Chartered Association of Certified Accountants qualification (the U.K. equivalent of our Certified Public Accountant).

Anita Ruka has served as Vice President of Human Resources since July 2011 and previously served as Executive Director, Organizational Development and Human Resources from November 2010 to July 2011. Prior to joining ZELTIQ, Ms. Ruka served as Director of Human Resources at eBioscience, Inc. from October 2008 to November 2010; Director of Human Resources at Greer Laboratories, Inc. from June 2003 to April 2007; Vice President Human Resources with CHC Industries, Inc. from 2001 to 2003 and Director of Human Resources with GE Medical, Inc. In her 25 years of experience, Ms. Ruka has developed expertise in teaming with executive leadership to build dynamic cultures, creating growth-oriented organizational models, mobilizing teams to achieve corporate goals, and building human resource functions. She holds a B.S.B.A. from University of Phoenix and is currently working toward an M.B.A.

Steve Watson has served as Vice President of S.T.E.P. since July 2011 and previously served as Director, S.T.E.P. from December 2010 to July 2011. Prior to joining ZELTIQ, Mr. Watson served as Director of Commercial Sales Operations & Sales Training at GE Healthcare in the Clinical Device Group from March 2005 to December 2010, and Director of Sales Training & Human Development at Misys Healthcare (now Allscripts) from June 2002 to March 2005. He is charged with utilizing the science of selling and research-based buying as well as matching new technologies with education execution, ultimately leading to consistent and repeatable performance success. Mr. Watson holds a B.A. in Economics and a B.A. in Sociology from Wofford College.

Ian P. West, Ph.D., C.Eng., FIET has served as Vice President of Product Development since April 2011. Prior to joining ZELTIQ, Dr. West served as Director of Engineering, OEM Monitoring at Philips Healthcare from January 2008 to March 2011 and Engineering General Manager, Specialty Monitoring at GE Healthcare from October 2001 to December 2007. Prior to October 2001, Dr. West served as Director of Program Management at Critikon LLC and in various management positions with Johnson & Johnson Medical, Inc. Dr. West earned his Ph.D. in Engineering and his B.Eng at the University of Liverpool, United Kingdom.